54 results
Page 3 of 3
6-K
EX-99.1
p91pw2v4
8 Apr 20
Zai Lab obtains rights to develop and exclusively commercialize REGN1979 in oncology in mainland China, Hong Kong, Taiwan and Macau
6:03am
6-K
EX-99.1
lo0f3nr
19 Mar 20
Current report (foreign)
7:53am
424B2
ud8ppv24pohq4vamrs21
24 Jan 20
Prospectus for primary offering
7:24am
424B5
12jkk7ee
21 Jan 20
Prospectus supplement for primary offering
5:31pm
6-K
EX-99.1
va7rkp1tgy1qfhyl54l
3 Sep 19
Current report (foreign)
7:40am
20-F/A
EX-10.15
vvh n5obatevh
23 Aug 19
Annual report (foreign) (amended)
5:00pm
20-F/A
EX-10.15
exvb9e
26 Jun 19
Annual report (foreign) (amended)
6:07am
6-K
EX-99.1
s10nqlow6b
3 Jun 19
Zai Lab Appoints Valeria Fantin, Ph.D., as Chief Scientific Officer
7:31am
6-K
EX-99.1
6r1zgtxhhx8ouw bzau
30 Nov 18
Comprehensive collaboration across three MacroGenics’ pipeline programs to accelerate and expand ongoing development
6:06am
20-F
EX-4.11
sudor cfz2izt04j
30 Apr 18
Annual report (foreign)
9:07am
20-F
8ygy5s4
30 Apr 18
Annual report (foreign)
9:07am